Sort
39,280 grants matching “leukemia”
Human natural killer cells: Advancing biology and clinical applications
$992,214Michael A Caligiuri · Beckman Research Institute/City Of Hope · R35 · FY2018 · CA
Development of Recombinant Toxins to Treat Hematologic Malignancies
$991,402Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Commercializing Praedicare Dx TM platform for guiding cancer treatments
$991,179Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2018 · CA
Condensates in Leukemias
$990,443Charles G. Mullighan · St. Jude Children'S Research Hospital · P01 · FY2025 · CA
A Training Program in Molecular Hematology
$990,317Robert I Handin · Harvard Medical School · T32 · FY2007 · HL
Understanding Hemotopoietic Neoplasias using Humanized Mice
$990,065Richard A Flavell · Yale University · R01 · FY2012 · CA
Clinical Trials with Immunotoxins
$989,879Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION
$989,863Dana-Farber Cancer Institute · P01 · FY2000 · AI
Mechanistic and translational studies of CBF leukemia
$989,695Paul Liu · National Human Genome Research Institute · ZIA · FY2014 · HG
Molecular and Cellular Regulation of Pre-Leukemic Stem Cells and their Therapeutic Targeting
$987,840Ulrich Steidl · Albert Einstein College Of Medicine · R35 · FY2022 · CA
Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of
$987,616Stig K. Hansen · Carmot Therapeutics, Inc. · R44 · FY2013 · CA
Programming T Cell Fates for Therapeutic Use
$987,437Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Telomere Diseases
$987,089Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Gene Expression Profiling/Chronic Lymphocytic Leukemia
$986,494Adrian U Wiestner · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Oncogenic NOTCH Signaling
$986,393Jon C Aster · Brigham And Women'S Hospital · P01 · FY2008 · CA
Sequencing and Integrated Analysis of AML Genomes
$986,260Richard K. Wilson · Washington University · P01 · FY2017 · CA
Dual-targeting allogeneic CAR T-cells for universal therapy of T-cell malignancies
$986,080Sarah Marie Hein · March Biosciences Inc · R44 · FY2025 · CA
Advanced Prodrug Treatment for CML
$985,960Milton H. Werner · Inhibikase Therapeutics · R44 · FY2019 · CA
Role Of Monocytes In Immunopathology
$985,363Larry M Wahl · Dental & Craniofacial Research · Z01 · FY2007 · DE
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
$985,350Jonah B. Sacha · Oregon Health & Science University · R01 · FY2022 · AI
Adoptive T cell Therapy for Pediatric Leukemia
$985,195Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
A phase II dose expansion clinical trial testing the efficacy of CD24Fc for the prophylaxis of severe graft vs host disease and leukemia relapse
$985,075Pan Zheng · Oncoimmune, Inc. · R44 · FY2020 · CA
Integrating Imaging-based Infrastructure into the INCLUDE Data Hub
$985,000Adam Cain Resnick · Children'S Hosp Of Philadelphia · U2C · FY2024 · HL
Programming T Cell Fates for Therapeutic Use
$984,972Luca Gattinoni · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Chemoprevention of Basal Cell Carcinomas with Tazarotene
$984,967Ervin H Epstein · Children'S Hospital & Res Ctr At Oakland · R01 · FY2007 · CA